Prevention
Breast Cancer Early Detection Policy
Links between lifestyle and breast cancer
It has been estimated that more than 22% of breast cancers in Australia can potentially be prevented by addressing the major modifiable risk factors for breast cancer such as overweight and obesity, physical inactivity, and alcohol use.(1)
Overweight and obesity, physical activity, and alcohol
An Australian analysis estimated that 6.6% of breast cancers diagnosed in 2013 among women aged up to 74 years could be attributed to overweight and obesity.(1) In 2017-18, 67% of women aged 55-64, and 73% of women aged 65-74 years were living with overweight or obesity.(2) The World Cancer Research Fund’s (WCRF) Continuous Update Project report concluded that there is strong evidence that adult body fatness increases the risk of post-menopausal breast cancer.(3) However, the WCRF has found probable evidence that body fatness in younger women aged 18-30 decreases the risk of pre-menopausal breast cancer.(3)
Physical activity and breast cancer risk has a dose-response relationship.(4, 5) Higher levels of physical activity are also inversely associated with both pre- and post-menopausal breast cancer, but this evidence is less consistent in pre-menopausal women.(6) The population attributable fraction (PAF) for breast cancers attributable to insufficient physical activity was 11.1% in 2015.(7)
The WCRF has found strong evidence that alcohol use increases the risk of breast cancer in both pre- and post-menopausal women.(3) Alcohol use and breast cancer risk has a dose-response relationship, particularly for long term use.(8) Multiple studies have demonstrated that alcohol use is associated with a 7-10% increase in breast cancer risk for each standard alcoholic drink per day.(9-12) In 2017-18, 10% of women aged 45-64, and 9% of women aged 65-74 years were in exceedence of the lifetime alcohol risk guidelines.(13) In Australia, it has been estimated that 6.4% of breast cancers diagnosed among women aged up to 74 years could be attributed to alcohol use.(1)
Further information on the risk factors of overweight, obesity, physical activity and alcohol, and their impact on the cancer burden in Australia can be found in the relevant policy documents on Cancer Council’s website.
Exogenous oestrogens
Hormone replacement therapy (HRT) is associated with increased breast cancer risk, in particular combination HRT (containing oestrogen and progestogen).(14-16) In 2019, the Collaborative Group on Hormonal Factors in Breast Cancer found one year use of HRT increased the risk of breast canccer among post-menopausal women, with the risk increasing the longer HRT was used.(17) It is estimated that the use of combined HRT for five years would cause an additional 15 to 20 breast cancer cases per 1,000 women.(17) Whilst the risk decreases within two years of HRT therapy ceasing(14), its magnitude is dependent on the duration of previous use, with low excess risk after less than one year of HRT use.(17) There has been little to no reported increase in risk for oestrogen-only HRT.(16, 17)
There is some evidence that use of some oral contraceptives (combined oral contraceptives) is associated with a small increase in breast cancer risk, with longer term users at higher risk.(18-21) For further information on the link between oral contraceptives and cancer, please visit Cancer Council’s oral contraceptives position statement.
Tobacco
The International Agency for Research on Cancer (IARC) states that there is accumulating evidence that tobacco use may be associated with breast cancer in women.(22) Analysis of 102,927 women from the prospective Breast Cancer Now Generations cohort study found that women who had ever smoked were 14% more likely to go on to develop breast cancer than those who had not, with the highest risk among women who began smoking at adolescent or peri-menarcheal ages.(23) The risk of breast cancer associated with smoking was found to be greatest for women with a family history of the disease.(23)
See Cancer Council’s tobacco policy for more information on the link between tobacco and cancer, and the disease burden from tobacco in Australia.
Non-modifiable risk factors
Some breast cancer risk factors cannot be modified through lifestyle or behavioural change. These include sex and age, family history of breast cancer, genetics, personal history of breast disease, and hormonal factors. Having an understanding of these risk factors is to key to ensuring there are appropriate targeted efforts for early detection in place, such as through risk-based breast cancer screening.
Sex and age
Breast cancer is much more common in women, compared to men (125.6 and 1.1 cases per 100,000, respectively).(24) Breast cancer risk increases with age. In Australia, the risk of being diagnosed with breast cancer for a woman before age 75 is approximately one in 10, versus one in 47 before the age of 50.(24) More than 80% of breast cancers in Australia are diagnosed in women over the age of 50.(25) It is important to note that the association between breast cancer and age is not due to overdiagnosis through screening. The median age of a breast cancer diagnosis in 1982 was 60.2 years, and in 1992, after the introduction of BreastScreen Australia, the median age was 60.4 years.(24)
Family history & genetics
Family history is an important risk factor for breast cancer. Evidence shows that there is a two-fold increase in risk of developing the disease for women with breast cancer in their first-degree family (parents, siblings, or children), and a larger increase in risk among women with a first-degree relative diagnosed ≤50 years.(26, 27) A smaller increase in breast cancer risk is associated with affected second-degree relatives (aunts, nieces, cousins, or grandparents).(28) However, 8 out of 9 women who develop breast cancer do not have a first-degree relative with breast cancer.(29)
The most common cause of a hereditary breast cancer is from a mutation in either the BRCA1 or BRCA2 genes. (30) BRCA1 and BRCA2 mutations are estimated to increase the cumulative risk of breast cancer by 72% and 60% respectively, to the age of 80 years.(31) Breast cancer incidences increased rapidly in early adulthood until ages 30-40 years for BRCA1 and until ages 40-50 for BRCA2 carriers, then remained at a similar, constant incidence until 80 years.(31)
Breast conditions
Personal history of breast cancer and other pre-invasive breast conditions is associated with increased breast cancer risk.(30, 32) Breast carcinoma in situ (when breast cells have the appearance of invasive cancer, but do not invade adjacent tissue) and benign breast disease (also known as fibrocystic disease) are both associated with increased risk of invasive breast cancer.(32)
Breast density
Mammographic breast density (MD) reflects the proportion of the breast composed of fibro-glandular tissue and is a strong risk factor for breast cancer.(33, 34) MD cannot be felt, but it can be seen on radiology scans. Radiologists can classify MD along a scale from mostly fatty (very low density) to mostly dense (extremely dense), using guidelines such as the American College of Radiology’s Breast Imaging Reporting and Data System (BI-RADS). Breast density can also be measured using imaging processing.(35)
Dense breasts are also associated with reduced sensitivity for detection of cancer, due to potential masking (hiding or camouflaging) of tumours.(33)
Extremely dense breasts on mammography are associated with a ≥2-fold increase in breast cancer risk in women aged 40-49, compared with breasts that were almost entirely fat.(18) A meta-analysis of observational studies demonstrated that the risk of breast cancer increased nearly 2-fold for each 25% increase in percent density in post-menopausal Asian women.(36) Breast density is partially modifiable and can be impacted by age, parity, weight, alcohol, diet, and hormone replacement therapy (HRT) use. On average, breast density is reduced with menopause, and by medications such as tamoxifen.(37, 38)
Hormonal factors
High endogenous oestrogen levels are associated with increased breast cancer risk for post-menopausal women,(39) with an estimated two-fold higher risk among women in the top 20-25% compared to bottom 20-25% of oestrogen levels.(40) However, no association has been confirmed in pre-menopausal women.
Early menarche (onset of menstrual periods) is associated with a slight increase in risk of breast cancer, particularly for women who had their first menstrual period before the age of 12 years.(41) Women with shorter menstrual cycles and later menopause are also at increased risk of breast cancer.(41)
Although to a lesser extent than other risk factors, reproductive history and breast-feeding also appear to influence breast cancer risk. The risk of breast cancer is lower in women who have children compared to those who have no children or have their first child at 30 years or older. (18, 42, 43) Breast cancer risk decreases by around 7% with each birth following the first.(44)
The World Cancer Research Fund (WCRF) has also found strong evidence to suggest that breastfeeding reduces the risk of breast cancer,(3) especially for women who breastfeed for more than 12-months, compared to shorter durations.(45-48) There is evidence to suggest that ever having breastfed is significantly associated with a reduced risk of developing luminal and triple-negative subtypes of breast cancer by 23% and 21%, respectively.(48)
References
- Wilson LF, Antonsson A, Green AC, Jordan SJ, Kendall BJ, Nagle CM, et al. How many cancer cases and deaths are potentially preventable? Estimates for Australia in 2013. International Journal of Cancer. 2018;142(4):691-701.
- Australian Institute of Health and Welfare. Overweight and obesity. Canberra: AIHW; 2023.
- World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Report: Diet, nutrition, physical activity and breast cancer. WCRF/ACIR; 2018.
- Wu Y, Zhang D, Kang S. Physical activity and risk of breast cancer: a meta-analysis of prospective studies. Breast Cancer Res Treat. 2013;137(3):869-82.
- Moore SC, Lee IM, Weiderpass E, Campbell PT, Sampson JN, Kitahara CM, et al. Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults. JAMA Internal Medicine. 2016;176(6):816.
- Chan DSM, Abar L, Cariolou M, Nanu N, Greenwood DC, Bandera EV, et al. World Cancer Research Fund International: Continuous Update Project—systematic literature review and meta-analysis of observational cohort studies on physical activity, sedentary behavior, adiposity, and weight change and breast cancer risk. Cancer Causes & Control. 2019;30(11):1183-200.
- Ellis L, Milne RL, Moore MM, Bigby KJ, Sinclair C, Brenner DR, et al. Estimating cancers attributable to physical inactivity in Australia. J Sci Med Sport. 2024;27(3):149-53.
- Jayasekara H, MacInnis RJ, Room R, English DR. Long-Term Alcohol Consumption and Breast, Upper Aero-Digestive Tract and Colorectal Cancer Risk: A Systematic Review and Meta-Analysis. Alcohol Alcohol. 2016;51(3):315-30.
- Shield KD, Soerjomataram I, Rehm J. Alcohol Use and Breast Cancer: A Critical Review. Alcohol Clin Exp Res. 2016;40(6):1166-81.
- Hamajima N, Hirose K, Tajima K, Rohan T, Calle EE, Heath CW, Jr., et al. Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer. 2002;87(11):1234-45.
- McDonald JA, Goyal A, Terry MB. Alcohol Intake and Breast Cancer Risk: Weighing the Overall Evidence. Current Breast Cancer Reports. 2013;5(3):208-21.
- Liu Y, Nguyen N, Colditz GA. Links between Alcohol Consumption and Breast Cancer: A Look at the Evidence. Women's Health. 2015;11(1):65-77.
- Australian Institute of Health and Welfare. Alcohol, tobacco & other drugs in Australia. Canberra: AIHW; 2024.
- Narod SA. Hormone replacement therapy and the risk of breast cancer. Nat Rev Clin Oncol. 2011;8(11):669-76.
- Marjoribanks J, Farquhar C, Roberts H, Lethaby A. Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev. 2012(7):Cd004143.
- Thorbjarnardottir T, Olafsdottir EJ, Valdimarsdottir UA, Olafsson O, Tryggvadottir L. Oral contraceptives, hormone replacement therapy and breast cancer risk: A cohort study of 16 928 women 48 years and older. Acta Oncologica. 2014;53(6):752-8.
- Collaborative Group on Hormonal Factors in Breast Cancer. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. The Lancet. 2019;394(10204):1159-68.
- Nelson HD, Zakher B, Cantor A, Fu R, Griffin J, O'Meara ES, et al. Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med. 2012;156(9):635-48.
- Zhu H, Lei X, Feng J, Wang Y. Oral contraceptive use and risk of breast cancer: a meta-analysis of prospective cohort studies. Eur J Contracept Reprod Health Care. 2012;17(6):402-14.
- Kahlenborn C, Modugno F, Potter DM, Severs WB. Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis. Mayo Clin Proc. 2006;81(10):1290-302.
- Mørch LS, Skovlund CW, Hannaford PC, Iversen L, Fielding S, Lidegaard Ø. Contemporary Hormonal Contraception and the Risk of Breast Cancer. New England Journal of Medicine. 2017;377(23):2228-39.
- International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans, volume 100E. A review of human carcinogens: Personal habits and indoor combustions. Lyon, France: IARC; 2012.
- Jones ME, Schoemaker MJ, Wright LB, Ashworth A, Swerdlow AJ. Smoking and risk of breast cancer in the Generations Study cohort. Breast Cancer Research. 2017;19(1).
- Australian Institute of Health and Welfare. Cancer data in Australia. Canberra: AIHW; 2023.
- Australian Institute of Health and Welfare. BreastScreen Australia monitoring report 2023. Canberra: AIHW; 2023.
- Barnard ME, Boeke CE, Tamimi RM. Established breast cancer risk factors and risk of intrinsic tumor subtypes. Biochim Biophys Acta. 2015;1856(1):73-85.
- Hemminki K, Granström C, Czene K. Attributable risks for familial breast cancer by proband status and morphology: A nationwide epidemiologic study from Sweden. International Journal of Cancer. 2002;100(2):214-9.
- Brewer HR, Jones ME, Schoemaker MJ, Ashworth A, Swerdlow AJ. Family history and risk of breast cancer: an analysis accounting for family structure. Breast Cancer Research and Treatment. 2017;165(1):193-200.
- Breast Cancer Network Australia. Family History - Fact Sheet. 2019.
- 30. American Cancer Society. Breast Cancer Risk Factors You Cannot Change 2023 [Available from: https://www.cancer.org/cancer/types/breast-cancer/risk-and-prevention/breast-cancer-risk-factors-you-cannot-change.html.
- Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips K-A, Mooij TM, Roos-Blom M-J, et al. Risks of Breast, Ovarian, and Contralateral Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers. JAMA. 2017;317(23):2402.
- National Breast and Ovarian Cancer Centre. Breast cancer risk factors: a review of the evidence. Surry Hills, NSW: National Breast and Ovarian Cancer Centre; 2009.
- Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, et al. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol. 2005;6(10):798-808.
- Vachon CM, Brandt KR, Ghosh K, Scott CG, Maloney SD, Carston MJ, et al. Mammographic breast density as a general marker of breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2007;16(1):43-9.
- Sak MA, Littrup PJ, Duric N, Mullooly M, Sherman ME, Gierach GL. Current and Future Methods for Measuring Breast Density: A Brief Comparative Review. Breast Cancer Manag. 2015;4(4):209-21.
- Bae JM, Kim EH. Breast Density and Risk of Breast Cancer in Asian Women: A Meta-analysis of Observational Studies. J Prev Med Public Health. 2016;49(6):367-75.
- Lindgren J, Dorgan J, Savage-Williams J, Coffman D, Hartman T. Diet across the Lifespan and the Association with Breast Density in Adulthood. International Journal of Breast Cancer. 2013;2013:1-26.
- Boyd NF. Mammographic Density and Risk of Breast Cancer. American Society of Clinical Oncology Educational Book. 2013(33):e57-e62.
- Walker K, Bratton DJ, Frost C. Premenopausal endogenous oestrogen levels and breast cancer risk: a meta-analysis. Br J Cancer. 2011;105(9):1451-7.
- Brown SB, Hankinson SE. Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers. Steroids. 2015;99(Pt A):8-10.
- Collaborative Group on Hormonal Factors in Breast Cancer. Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. The Lancet Oncology. 2012;13(11):1141-51.
- Park B, Park S, Shin H-R, Shin A, Yeo Y, Choi J-Y, et al. Population attributable risks of modifiable reproductive factors for breast and ovarian cancers in Korea. BMC Cancer. 2016;16(1).
- Cancer Australia. Breast Cancer - Risk factors Australian Government; 2024 [Available from: https://www.breastcancerriskfactors.gov.au/node/55.
- Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet. 2002;360(9328):187-95.
- Anothaisintawee T, Wiratkapun C, Lerdsitthichai P, Kasamesup V, Wongwaisayawan S, Srinakarin J, et al. Risk factors of breast cancer: a systematic review and meta-analysis. Asia Pac J Public Health. 2013;25(5):368-87.
- Bernier MO, Plu-Bureau G, Bossard N, Ayzac L, Thalabard JC. Breastfeeding and risk of breast cancer: a metaanalysis of published studies. Hum Reprod Update. 2000;6(4):374-86.
- Zhou Y, Chen J, Li Q, Huang W, Lan H, Jiang H. Association between breastfeeding and breast cancer risk: evidence from a meta-analysis. Breastfeed Med. 2015;10(3):175-82.
- Lambertini M, Santoro L, Del Mastro L, Nguyen B, Livraghi L, Ugolini D, et al. Reproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis of epidemiological studies. Cancer Treat Rev. 2016;49:65-76.
Explore our Early Detection Policy.